221 related articles for article (PubMed ID: 15018923)
1. QSAR study on some anti-HIV HEPT analogues using physicochemical and topological parameters.
Gayen S; Debnath B; Samanta S; Jha T
Bioorg Med Chem; 2004 Mar; 12(6):1493-503. PubMed ID: 15018923
[TBL] [Abstract][Full Text] [Related]
2. QSAR for anti-HIV activity of HEPT derivatives.
Bazoui H; Zahouily M; Boulajaaj S; Sebti S; Zakarya D
SAR QSAR Environ Res; 2002 Oct; 13(6):567-77. PubMed ID: 12479372
[TBL] [Abstract][Full Text] [Related]
3. A 3D QSAR study of a series of HEPT analogues: the influence of conformational mobility on HIV-1 reverse transcriptase inhibition.
Kireev DB; Chrétien JR; Grierson DS; Monneret C
J Med Chem; 1997 Dec; 40(26):4257-64. PubMed ID: 9435895
[TBL] [Abstract][Full Text] [Related]
4. Neural networks: Accurate nonlinear QSAR model for HEPT derivatives.
Douali L; Villemin D; Cherqaoui D
J Chem Inf Comput Sci; 2003; 43(4):1200-7. PubMed ID: 12870912
[TBL] [Abstract][Full Text] [Related]
5. Anti-HIV activity of HEPT, TIBO, and cyclic urea derivatives: structure-property studies, focused combinatorial library generation, and hits selection using substructural molecular fragments method.
Solov'ev VP; Varnek A
J Chem Inf Comput Sci; 2003; 43(5):1703-19. PubMed ID: 14502505
[TBL] [Abstract][Full Text] [Related]
6. A novel simple QSAR model for the prediction of anti-HIV activity using multiple linear regression analysis.
Afantitis A; Melagraki G; Sarimveis H; Koutentis PA; Markopoulos J; Igglessi-Markopoulou O
Mol Divers; 2006 Aug; 10(3):405-14. PubMed ID: 16896545
[TBL] [Abstract][Full Text] [Related]
7. Artificial neural networks: non-linear QSAR studies of HEPT derivatives as HIV-1 reverse transcriptase inhibitors.
Douali L; Villemin D; Zyad A; Cherqaoui D
Mol Divers; 2004; 8(1):1-8. PubMed ID: 14964783
[TBL] [Abstract][Full Text] [Related]
8. QSAR models for HEPT derivates as NNRTI inhibitors based on Monte Carlo method.
Toropova AP; Toropov AA; Veselinović JB; Miljković FN; Veselinović AM
Eur J Med Chem; 2014 Apr; 77():298-305. PubMed ID: 24657566
[TBL] [Abstract][Full Text] [Related]
9. Quantitative structure-activity relationship studies on 2-amino-6-arylsulfonylbenzonitriles as human immunodeficiency viruses type 1 reverse transcriptase inhibitors using descriptors obtained from substituents and whole molecular structures.
Hemmateenejad B; Sabet R; Fassihi A
Chem Biol Drug Des; 2009 Oct; 74(4):405-15. PubMed ID: 19691465
[TBL] [Abstract][Full Text] [Related]
10. 2-(Aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT inhibitors.
Rawal RK; Prabhakar YS; Katti SB; De Clercq E
Bioorg Med Chem; 2005 Dec; 13(24):6771-6. PubMed ID: 16198576
[TBL] [Abstract][Full Text] [Related]
11. QSAR by LFER model of cytotoxicity data of anti-HIV 5-phenyl-1-phenylamino-1H-imidazole derivatives using principal component factor analysis and genetic function approximation.
Roy K; Leonard JT
Bioorg Med Chem; 2005 Apr; 13(8):2967-73. PubMed ID: 15781406
[TBL] [Abstract][Full Text] [Related]
12. Conformational study of the HIV-1 reverse transcriptase inhibitor 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT).
Lawtrakul L; Hannongbua S; Beyer A; Wolschann P
Biol Chem; 1999 Feb; 380(2):265-7. PubMed ID: 10195434
[TBL] [Abstract][Full Text] [Related]
13. Quantitative structure-activity relationship study on the anti-HIV-1 activity of novel 6-naphthylthio HEPT analogs.
Riahi S; Pourbasheer E; Dinarvand R; Ganjali MR; Norouzi P
Chem Biol Drug Des; 2009 Aug; 74(2):165-72. PubMed ID: 19549086
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of 2-(2,6-dihalophenyl)-3-pyrimidinyl-1,3-thiazolidin-4-one analogues as anti-HIV-1 agents.
Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
Bioorg Med Chem; 2007 May; 15(9):3134-42. PubMed ID: 17349793
[TBL] [Abstract][Full Text] [Related]
15. QSAR modeling of HIV-1 reverse transcriptase inhibitor 2-amino-6-arylsulfonylbenzonitriles and congeners using molecular connectivity and E-state parameters.
Roy K; Leonard JT
Bioorg Med Chem; 2004 Feb; 12(4):745-54. PubMed ID: 14759734
[TBL] [Abstract][Full Text] [Related]
16. Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 11: structural modulations of diaryltriazines with potent anti-HIV activity.
Xiong YZ; Chen FE; Balzarini J; De Clercq E; Pannecouque C
Eur J Med Chem; 2008 Jun; 43(6):1230-6. PubMed ID: 17869386
[TBL] [Abstract][Full Text] [Related]
17. Comparative QSAR based on neural networks for the anti-HIV activity of HEPT derivatives.
Douali L; Villemin D; Cherqaoui D
Curr Pharm Des; 2003; 9(22):1817-26. PubMed ID: 12871199
[TBL] [Abstract][Full Text] [Related]
18. 3D-QSAR and docking studies on the HEPT derivatives of HIV-1 reverse transcriptase.
Latha RS; Vijayaraj R; Singam ER; Chitra K; Subramanian V
Chem Biol Drug Des; 2011 Sep; 78(3):418-26. PubMed ID: 21689378
[TBL] [Abstract][Full Text] [Related]
19. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
Mandal AS; Roy K
Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
[TBL] [Abstract][Full Text] [Related]
20. Application of ant colony optimization in development of models for prediction of anti-HIV-1 activity of HEPT derivatives.
Zare-Shahabadi V; Abbasitabar F
J Comput Chem; 2010 Sep; 31(12):2354-62. PubMed ID: 20575016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
